Sesame, a low-cost healthcare platform, has integrated with Gifthealth to provide streamlined access to Eli Lilly's Zepbound obesity medication. The partnership allows clinically eligible patients to purchase Zepbound at reduced prices ($349-$499 per single-vial dose) through their 'Success by Sesame' weight loss program, which costs $89 monthly and includes comprehensive clinical support.